English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[1121]
News
[2443]
Articles
[147]
Editorials
[8]
Conferences
[101]
e
learning
[12]
Pembrolizumab a promising option for MIUC patients after radical surgery
Dr Andrea Apolo - National Cancer Institute, Bethesda, USA
5 Feb 2024
ASCO GU 2024: Current best practice for mRCC
Prof Jens Bedke, Prof Thomas Powles, Prof Michael Staehler and Dr Wenxin Xu
1 Feb 2024
ASCO GU 2024: Latest in PARP inhibitors for prostate cancer
Dr Friederike Schlurmann, Dr Nabil Adra, Dr Emmanuel Antonarakis and Dr Hiroshi...
31 Jan 2024
Remote genetic testing has the potential to increase the uptake of testing in...
Dr Bruce Montgomery - University of Washington, Seattle, USA
31 Jan 2024
Stockholm3 offers a promising avenue for personalised risk-based prostate...
Dr Scott Eggener - The University of Chicago, Chicago, USA
31 Jan 2024
Cabozantinib and atezolizumab show more efficacy compared to second NHT in...
Prof Neeraj Agarwal - University of Utah, Salt Lake City, USA
30 Jan 2024
Baseline characteristics of patients with PSMA-PET–positive and –negative...
Prof Boris Hadaschik - University of Duisburg-Essen, Essen, Germany
30 Jan 2024
Enfortumab vedotin in combination with pembrolizumab is a potential new...
Dr Michiel Simon Van Der Heijden - Netherlands Cancer Institute, Amsterdam...
30 Jan 2024
Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with...
Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA
30 Jan 2024
Personalised systemic treatment in advanced prostate cancer
Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France
25 Jan 2024
World Bladder Cancer Patient Coalition
Dr Lydia Makaroff - President, World Bladder Cancer Patient Coalition, Oxford...
8 Jan 2024
DNA methylation profile of prostate cancer aggressiveness in Ghana
Dr Alexandra Lindsey Djomkam Zune - West African Centre for Cell Biology of...
3 Jan 2024
<
1
2
3
4
5
6
7
...
94
>
More from
e
cancer